The popular smoking-cessation drug Chantix does not increase the risk of heart attacks, strokes and other cardiovascular problems, according to a University of California, San Francisco study that challenges an earlier, widely circulated report that suggested the medication was dangerous.

The new study does not address some of the other concerns around Chantix – notably, its association with psychiatric problems, including reports of people becoming depressed and even suicidal while taking the drug. Chantix prescriptions come with strong warnings, mandated by the FDA, about the possibility of psychiatric problems.

That is why the drug is dangerous and naturally they didn’t add that to the study.



Leave a Reply

Avatar placeholder